Technology Supported Education Program Based on Human Care Theory
The Effect of Technology Supported Education Program Based on Human Care Theory on Knowledge, Self-Efficacy, Quality of Life and Anxiety of Parents of Children with Stem Cell Transplantation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Duygu Altuntaş, MSc
- Phone Number: +0905518627252
- Email: duygualtuntas@akdeniz.edu.tr
Study Locations
-
-
-
Antalya, Turkey
- Akdeniz University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Primary care parent of the child (0-18 years old) after HSCT
- Having mobile internet access
- Discharge planned
Exclusion Criteria:
- Parent's failure to attend at least 3 sessions of the training program
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: İntervention group
The sample of the study will be the parents of children who have had hematopoietic stem cell transplantation at Akdeniz University Hospital and whose discharge is planned (n=20).
|
IBK-EBP will be administered to parents in six sessions in six days.
After six days of training, the mobile application will be used by parents for 8 weeks.
The frequency of use of the mobile application will be left entirely to the needs of the parents and reminders will be made through the mobile application.
In addition, the video used during the face-to-face training, progressive relaxation exercise videos and motivational sentences will also be included in the mobile application.
|
|
No Intervention: Control group
The control group will be the parents of children who underwent hematopoietic stem cell transplantation at Akdeniz University Hospital and are planned to be discharged (n=20).
Participants in this group will receive routine care, and at the end of the study, training program will be applied.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge
Time Frame: 1 year
|
There are 13 questions in the questionnaire prepared in line with the literature.
The questions will be answered as "strongly agree", "agree", "undecided", "disagree", "strongly disagree".
|
1 year
|
|
Self-Efficacy
Time Frame: 1 year
|
Generalized Self-Efficacy Scale, developed by Schwarzer and Jarusalem (1995) and validated in Turkish by Aypay (2010), consists of 10 items in total.
The response category is a 4-point scale and is scored as "Totally wrong = 1 point", "Slightly correct = 2 points", "Moderately correct = 3 points", "Totally correct = 4 points".
There is no inverse item and cut-off point in the scale.
The lowest 10 and the highest 40 points are taken from the scale.
It is interpreted as "perceived self-efficacy increases as the scale score increases".
|
1 year
|
|
Quality Life
Time Frame: 1 year
|
The Caregiver Quality of Life Index Cancer Scale (CQOLC), developed by Weitzner et al. (1999), aims to measure caregivers' quality of life, including their physical, emotional, familial and social functions.
The total score of each sub-dimension and scale in the scale ranges from 0 to 140.
In the scale, financial distress, discomfort sub-dimensions and some questions consist of reversed statements.
The scale contains a total of 35 items.
|
1 year
|
|
Anxiety
Time Frame: 1 hyear
|
It consists of 2 subscales, namely state and trait anxiety.
State Anxiety Sub-Scale (STAI-S), an individual's at a certain time and under certain conditions; The Trait Anxiety Subscale (STAI-T) usually requires a description of how one feels.
The inventory is answered via 4-point scales.
The emotions and behaviors expressed in the items of the State Anxiety Sub-Scale are indicated by choosing one of the options "(1) Not at all, (2) A little, (3) A lot and (4) Completely" according to the severity of such experiences.
Emotions and behaviors expressed in Trait Anxiety Sub-Scale items are according to their frequency levels; It is marked as (1) Almost Never, (2) Sometimes, (3) Often, and (4) Almost Always.
|
1 hyear
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Satisfaction Evaluation Form According to Watson Improvement Processes
Time Frame: 1 year
|
Watson is a form developed by Watson et al. (2010) to evaluate IBC-based nursing care.
This satisfaction form is not a scale.
The form consists of six questions in total.
The first five questions are scored between 1 and 7, and are evaluated as never (1) and always (7).
The sixth question is in the form of an open-ended question in which the "moments of care" in the given nursing care are evaluated.
|
1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Emine EFE, Proff.Dr., Akdeniz University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- Akdenizuni
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.